Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Activation of the astrocytic Nrf2/ARE system ameliorates the formation of demyelinating lesions in a multiple sclerosis animal model.
How do Australians living with MS experience oral health and accessing dental care? A focus group study.
Lamivudine and fingolimod co-administration in two patients with multiple sclerosis and occult hepatitis B virus infection.
Effects of sphingosine-1-phosphate receptor 1 phosphorylation in response to FTY720 during neuroinflammation.
The Anti-dementia Drug Candidate, (-)-Clausenamide, Improves Memory Impairment through its Multi-target Effect.
Mobitz type I and II atrioventricular blocks during fingolimod therapy.
Fingolimod-induced leukoencephalopathy in a patient with neuromyelitis optica spectrum disorder.
CX3CR1-dependent recruitment of mature NK cells into the central nervous system contributes to control autoimmune neuroinflammation.
Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls.
Molecular characterization of biotic and abiotic stress-responsive MAP kinase genes, IbMPK3 and IbMPK6, in sweetpotato.
MRI Patterns of Isolated Lesions in the Medulla Oblongata.
Dyschromatopsia in Multiple Sclerosis Patients: A Marker of Subclinical Involvement?
Loss of Myelin Basic Protein Function Triggers Myelin Breakdown in Models of Demyelinating Diseases.
Movement-to-music (m2m) As An Alternative Form Of Exercise Rehabilitation For An Individual With Multiple Sclerosis: 1568 Board #221 June 2, 8: 00 AM - 9: 30 AM.
Increased incidence of rheumatoid arthritis in multiple sclerosis: A nationwide cohort study.
Fatigue Improvement after Switching Multiple Sclerosis Treatment from Interferon-β to Glatiramer Acetate in Clinical Practice.
[Expression of chemokine like factor-like myelin and lymphocyte and related proteins for vesicle trafficking and membrane link transmembrane domain-containing protein 2 in rats with varicocele].
The quality of cortical network function recovery depends on localization and degree of axonal demyelination.
Tuning PAK Activity to Rescue Abnormal Myelin Permeability in HNPP.
Mercy killing in neurology: The beginnings of neurology on screen (II).
The effect of transplanted human Wharton's jelly mesenchymal stem cells treated with IFN-γ on experimental autoimmune encephalomyelitis mice.
Evolving Concepts in Posterior Subthalamic Area Deep Brain Stimulation for Treatment of Tremor: Surgical Neuroanatomy and Practical Considerations.
Mast cells: New therapeutic target in helminth immune modulation.
Radiologically isolated syndrome: An update on a rare entity.
An idiopathic thrombocytopenic purpura with polyneuropathy.
Pages
« first
‹ previous
…
812
813
814
815
816
817
818
819
820
…
next ›
last »